Advisor Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Advisor Group’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$13K	Hold	189	–	–	﹤0.01%	4217
2019 Q3	$10K	Hold	189	–	–	﹤0.01%	4369
2019 Q2	$9K	Sell	189 -325	-63%	-$15.8K	﹤0.01%	4452
2019 Q1	$27K	Hold	514	–	–	﹤0.01%	3817
2018 Q4	$25K	Buy	514 +325	+172%	+$17.9K	﹤0.01%	3676
2018 Q3	$12K	Buy	+189	New	+$11.1K	﹤0.01%	4209
2017 Q2	–	Sell	-50	Closed	-$1K	–	4975
2017 Q1	$1K	Buy	+50	New	+$641	﹤0.01%	4621

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Advisor Group's MYOK Position: Q4 2019 in Review

Advisor Group held its MyoKardia, Inc. Common Stock (MYOK) position steady in Q4 2019 at 189 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #4217.

Advisor Group first reported a position in MYOK in Q1 2017 and has held it in 7 quarters since. The position peaked at $27K in Q1 2019. 178 funds tracked by Wall St. Rank hold MYOK as of Q4 2019.

Advisor Group held 189 shares of MyoKardia, Inc. Common Stock worth $13K as of Q4 2019.
Advisor Group left its MyoKardia, Inc. Common Stock share count unchanged in Q4 2019.
MyoKardia, Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4217 holding.
Advisor Group first reported a position in MyoKardia, Inc. Common Stock in Q1 2017 and has held it in 7 quarters since.
Advisor Group's MyoKardia, Inc. Common Stock position peaked at $27K in Q1 2019.
178 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.